Obstetrics and Gynecology

Michael J. Goodheart, MD


Fellowship Director
Assistant Professor
Assistant Professor of Obstetrics and Gynecology  - Gynecologic Oncology
Assistant Professor of Anatomy and Cell Biology

Contact Information

Primary Office: 31508 PFP
200 Hawkins Dr
Iowa City, IA 52242
Phone: 319-356-2015

Email: michael-goodheart@uiowa.edu


BA, Chemistry, North Carolina State University, Raleigh, North Carolina
BS, North Carolina State University, Raleigh, North Carolina
MD, Medicine, East Carolina State University School of Medicine, Greenville, North Carolina

Residency, Obstetrics and Gynecology, Louisiana State University School of Medicine, New Orleans, Louisiana
Residency, Surgery, University of South Florida School of Medicine, Tampa, Florida
Fellowship, Gynecologic Oncology, University of Iowa Hospitals and Clinics, Iowa City, Iowa

Licensure and Certifications

Board Certified, Gynecologic Oncology, ABOG
General Obstetrics and Gynecology
Iowa Medical License, #33538

Research Summary

Relating p53 mutation types to angiogenesis and immunohistochemical expression in epithelial ovarian cancers, and mutations of the BRCA2 gene in ovarian cancers.

Transcriptional regulation of the lymphoid enhancer factor-1 (Lef-1) promoter and its relevance in the pathogenesis of ovarian and endometrial cancer.

Selected Publications

Show All

Nadkarni N, Geest K, Neff T, Young B, Bender D, Ahmed A, Smith B, Button A, Goodheart M.  Microvessel density and p53 mutations in advanced-stage epithelial ovarian cancer..  Cancer letters.  2013 April. 331(1):99-104.

Schrepf A, Clevenger L, Christensen D, DeGeest K, Bender D, Ahmed A, Goodheart M, Dahmoush L, Penedo F, Lucci J, Ganjei-Azar P, Mendez L, Markon K, Lubaroff D, Thaker P, Slavich G, Sood A, Lutgendorf S.  Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability..  Brain, behavior, and immunity.  2013 March. 30 Suppl:S126-34.

Clevenger L, Schrepf A, Christensen D, DeGeest K, Bender D, Ahmed A, Goodheart M, Penedo F, Lubaroff D, Sood A, Lutgendorf S.  Sleep disturbance, cytokines, and fatigue in women with ovarian cancer..  Brain, behavior, and immunity.  2012 October. 26(7):1037-44.

Engle D, Connor J, Morris P, Bender D, De Geest K, Ahmed A, Goodheart M.  Intraoperative autologous blood transfusion use during radical hysterectomy for cervical cancer: long-term follow-up of a prospective trial..  Archives of gynecology and obstetrics.  2012 September. 286(3):717-21.

Abu-Hejleh T, Mezhir J, Goodheart M, Halfdanarson T.  Incidence and management of gastrointestinal perforation from bevacizumab in advanced cancers..  Current oncology reports.  2012 August. 14(4):277-84.

Lutgendorf S, De Geest K, Bender D, Ahmed A, Goodheart M, Dahmoush L, Zimmerman M, Penedo F, Lucci J, Ganjei-Azar P, Thaker P, Mendez L, Lubaroff D, Slavich G, Cole S, Sood A.  Social influences on clinical outcomes of patients with ovarian cancer..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology.  2012 August. 30(23):2885-90.

Shelton D, Fornalik H, Neff T, Park S, Bender D, DeGeest K, Liu X, Xie W, Meyerholz D, Engelhardt J, Goodheart M.  The role of LEF1 in endometrial gland formation and carcinogenesis..  PloS one.  2012 July 6. 7(7):e40312.

Leslie K, Thiel K, Goodheart M, De Geest K, Jia Y, Yang S.  Endometrial cancer..  Obstetrics and gynecology clinics of North America.  2012 June. 39(2):255-68.

Devor E, DE Mik J, Ramachandran S, Goodheart M, Leslie K.  Global dysregulation of the chromosome 14q32 imprinted region in uterine carcinosarcoma..  Experimental and therapeutic medicine.  2012 April. 3(4):677-682.

Goodheart M, Jacobson G, Smith B, Zhou L.  Chemoradiation for invasive cervical cancer in elderly patients: outcomes and morbidity..  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.  2008 January. 18(1):95-103.

Date Last Modified: 06/06/2016 - 13:17:48